Extendicare reported a strong third quarter with significant organic growth and successful acquisitions in the Home health care segment. Financial metrics such as EBITDA and margins showed positive trends. However, there were challenges in the Managed Services segment and some delays in construction projects.

Company Guidance

During Extendicare Inc.'s Third Quarter 2025 Analyst Conference Call, the company reported strong financial performance and strategic growth. Driven by a 13% year-over-year organic growth in Home health care volumes and the full impact of the Closing the Gap acquisition, the company's consolidated Q3 revenue increased by 22.6% to $440.3 million. The acquisition contributed $24 million in revenue and $3.1 million in NOI, while adjusted EBITDA rose to $50.8 million, a 40.6% increase from the prior year. Home health care NOI margin improved by 230 basis points to 13.6%. The company also expanded its senior secured credit facility by $100 million to support acquisitions, maintaining liquidity with $166 million in cash and access to a $154 million revolving credit facility. Additionally, Extendicare's AFFO increased to $0.31 per share, up 19.3% year-over-year, reducing the payout ratio to 45% on a trailing 12-month basis. The company's ongoing redevelopment agenda includes six homes under construction, aiming to introduce 1,408 new beds, with a $565 million development cost funded through a joint venture with Axium. The company remains committed to expanding Long-Term Care capacity and enhancing its Home health care services through strategic acquisitions and capital-efficient growth.

Strong Organic Growth and Acquisitions

Q3 saw strong organic growth, with Home health care volumes at ParaMed increasing by 13% year-over-year. The acquisition of Closing the Gap contributed $24 million in revenue and $3.1 million in NOI, exceeding expectations.

Financial Performance and Margin Improvements

Adjusted EBITDA increased by 40.6% to $50.8 million, with Home health care leading the way. Home health care NOI margin improved by 230 basis points to 13.6%. AFFO increased to $0.31 per share, up 19.3% year-over-year.

Expansion in Long-Term Care Segment

Six homes under construction will add 1,408 new beds, replacing 1,097 Class C beds. A new 320-bed home in Sudbury is planned to start construction by the end of the year.

Liquidity and Credit Facility

Extended senior secured credit facility by $100 million, maintaining favorable liquidity with cash on hand of $166 million and access to a further $154 million under a revolving credit facility.

Extendicare (TSE:EXE) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

TSE:EXE Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Feb 26, 2026	2025 (Q4)	0.27 / -	0.23	―	―	―
Nov 11, 2025	2025 (Q3)	0.20 / 0.28	0.19	47.89% (+0.09)	―	―
Aug 06, 2025	2025 (Q2)	0.18 / 0.37	0.29	28.62% (+0.08)	―	―
May 06, 2025	2025 (Q1)	0.16 / 0.18	0.15	17.33% (+0.03)	―	―
Feb 27, 2025	2024 (Q4)	0.17 / 0.23	0.1	130.00% (+0.13)	―	―
Nov 12, 2024	2024 (Q3)	- / 0.19	0.14	35.71% (+0.05)	―	―
Aug 12, 2024	2024 (Q2)	- / 0.29	0.02	1350.00% (+0.27)	―	―
May 15, 2024	2024 (Q1)	- / 0.15	0.14	7.14% (<+0.01)	―	―
Mar 08, 2024	2023 (Q4)	- / 0.10	-0.09	211.11% (+0.19)	―	―
Nov 09, 2023	2023 (Q3)	- / 0.14	-0.04	450.00% (+0.18)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

TSE:EXE Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 11, 2025	C$15.91	C$18.40	+15.65%
Aug 06, 2025	C$12.56	C$12.52	-0.32%
May 06, 2025	C$14.26	C$13.42	-5.89%
Feb 27, 2025	C$11.29	C$12.09	+7.09%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Extendicare (TSE:EXE) report earnings?

Extendicare (TSE:EXE) is schdueled to report earning on Feb 26, 2026, After Close (Confirmed).

What is Extendicare (TSE:EXE) earnings time?

Extendicare (TSE:EXE) earnings time is at Feb 26, 2026, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is TSE:EXE EPS forecast?

TSE:EXE EPS forecast for the fiscal quarter 2025 (Q4) is 0.27.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing